BROADWOOD CAPITAL INC Long-Term Concentrated

CIK: 0001278387 · Show all filings

Period: Q2 2019 (← Previous) (Next →)

Filing Date: Aug 14, 2019

Total Value ($000): $799,836 (100.0% shares, 0.0% debt)

Holdings (7)

STAA STAAR SURGICAL CO 39.8%

Value ($000) $318,498 Shares 10,840,630 Est. Cost $8.21 Unrealized +251.6%

MNST MONSTER BEVERAGE CORP NEW 37.3%

Value ($000) $298,680 Shares 4,679,308 Est. Cost $22.71 Unrealized +32.7%

IWM ISHARES TR 8.2%

Value ($000) $65,310 Shares 420,000 Est. Cost $109.78 Unrealized —

AXON AXON ENTERPRISE INC 6.1%

Value ($000) $48,804 Shares 760,062 Est. Cost $27.50 Unrealized +137.2%

— BIOTIME INC 4.7%

Value ($000) $37,379 Shares 33,980,826 Est. Cost $3.14 Unrealized —

— ONCOCYTE CORPORATION 2.5%

Value ($000) $20,165 Shares 8,098,267 Est. Cost $3.91 Unrealized —

— AGEX THERAPEUTICS INC 1.4%

Value ($000) $11,000 Shares 2,997,156 Est. Cost $2.99 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
STAA	STAAR SURGICAL CO	10,840,630	$318,498	39.8%	$8.21	+251.6%	COM PAR $0.01	852312305
MNST	MONSTER BEVERAGE CORP NEW	4,679,308	$298,680	37.3%	$22.71	+32.7%	COM	61174X109
IWM	ISHARES TR	420,000	$65,310	8.2%	$109.78	—	RUSSELL 2000 ETF	464287655
AXON	AXON ENTERPRISE INC	760,062	$48,804	6.1%	$27.50	+137.2%	COM	05464C101
—	BIOTIME INC	33,980,826	$37,379	4.7%	$3.14	—	COM	09066L105
—	ONCOCYTE CORPORATION	8,098,267	$20,165	2.5%	$3.91	—	COM	68235C107
—	AGEX THERAPEUTICS INC	2,997,156	$11,000	1.4%	$2.99	—	COM	00848H108